RE:RE:Holding/Plateaunarmac, so if I understand your points about BoM phlll and all of the other, rather remarkable results, like retinosis pigmentosis, the New Zealand dialysis trial, FSHD muscular dystrophy, the potential for some impact on Alzheimers, diabetes mellitus, etc (in effect many diseases related to inflammation???) are not currently built into the share price? Correct?
I sure agree with that, if that is what you are saying.
Regarding the share ownership structure one of the key attractions to me is to have companies like Eastern, Shenzen Hepalink, NGN Capital and CD Ventures holding large blocks of shares because each of these organizations have significant numbers of scientific experts and I'm sure each have analysed RVX up down and sideways before they put their money in. Also, that big players have come in knowing full well who else is invested suggests to me they must be comfortable with these partners and are willing to share risk with them.
In the 48.3% of shareholders I know of at least one that is a practising doctor in the area of cardio and other diseases. I know this because he/she posts (ed) on Agora providing some excellent insight regarding use of other drugs. So who knows the strange mix of people in the widely held category but when things begin to fall together there may well be a made rush of speculators, etc.
In terms of the next licensing deal, given the amount of scientific knowledge that has been gained about apabetalone since the Shenzen Hepalink deal, I am sure Don is negotiating a big price tag for this round. And with every DSMB report, each new indeppendent discovery about apabetalone, with each month we move closer to the futility analysis, etc the price will get higher of insiders.
On the point I made about Zenith everyone should check out BDAZ's posts on the Agora Zenith discussion board. We possibly could see some new findings regarding zen3694 on mCRPC on Mar 31 in the abstract to be presented in early April.
So when I see all the remarkable complex work and brilliant science produced by Resverlogix and Zenith I am dumbfounded by Snapchat being valued at $25 billion USD!!! What a crazy world.
GLTA
Toinv